Twist Bioscience Corp (TWST)
Healthcare
Diagnostics & Research
101.10 $
+10.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Twist Bioscience Corp (TWST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -23 | -21 | -23 | -19 | -6.4 | -15 | -21 | -13 | -1.4 | -12 | -25 | -18 | -56 | |
| 8.5 | 8.5 | 8.2 | 8.3 | 8.3 | 6.7 | 6.4 | 6.4 | 6.1 | 6.0 | 6.2 | 6.4 | 25 | |
| 11 | 12 | 11 | 14 | 14 | 12 | 12 | 20 | 16 | 16 | 13 | 19 | 64 | |
| 14 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 12 | 0.4 | 0.5 | 3.5 | 13 | -1.1 | -8.2 | -1.2 | 3.8 | -7.0 | -13 | 1.6 | -15 | |
| 4.5 | 2.4 | 1.5 | 0.6 | 1.0 | 2.0 | 2.3 | 4.1 | 9.2 | 12 | 10.0 | 8.0 | 40 | |
| 19 | -2.2 | 4.2 | -5.2 | -0.7 | -1.3 | -1.5 | -1.4 | -9.4 | -12 | -9.9 | -13 | -44 | |
| -1.0 | -1.1 | -2.4 | -1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.7 | 0.4 | -1.5 | 1.8 | 2.9 | 3.6 | 18 | 3.2 | 1.8 | 5.6 | 0.3 | 4.1 | 12 | |
| -5.7 | -23 | -20 | -23 | -4.2 | -13 | -5.1 | -11 | -9.0 | -18 | -34 | -26 | -88 | |
| -28 | -23 | -24 | -20 | -7.3 | -17 | -24 | -17 | -11 | -24 | -35 | -26 | -95 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.